fda food and drug administration news - Search News

FDA approves a new type of schizophrenia drug

Barron's on MSN · 36m

Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.

Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This drug takes the first new approach to schizophrenia treatment in decades,” the Food and Drug Administration said.

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

Bristol Myers wins US FDA approval for new type of schizophrenia drug

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades.

FDA issues recall notices for two brands of pet food

YAHOO!News · 17h

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

USA TODAY on MSN · 23h

ANSWERS Pet Food recalled over salmonella, listeria concerns: What pet owners need to know

ANSWERS Pet Food is voluntarily recalling several of its products due to potential salmonella and listeria exposure, according to the FDA.

FOX News on MSN · 1d

Pet food recalled over possible salmonella, listeria contamination

Dog food sold online and in stores is being recalled after tests conducted by federal health officials revealed the presence of both listeria and salmonella.

FDA, Esta and Labs

Seeking Alpha on MSN · 16h

Establishment Labs gets FDA approval for Motiva implants

Establishment Labs (NASDAQ:ESTA) said it has received FDA approval for the use of its Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round breast implants for primary and revision breast augmentation.

MarketWatch · 2h

Establishment Labs Shares Surge Premarket on FDA Breast Implant Approval

Establishment Labs Holdings shares jumped nearly 30% in premarket trading Friday after the medical-technology company won Food and Drug Administration approval for its Motiva breast implants. After the closing bell Thursday,

Business Insider · 7h

Buy Rating Affirmed: Establishment Labs’ Motiva Implant Poised to Disrupt the US Breast Implant Market

Josh Jennings, an analyst from TD Cowen, reiterated the Buy rating on Establishment Labs Holdings (ESTA – Research Report). The

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 18h

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 17h

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 19h

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

30m

Severity of various FDA product recalls including Class I which can cause death, serious illness

Hundreds of foods are recalled by the FDA every year. Food recalls could fall into different categories, depending on how ...

The Washington Post14h

FDA approves a novel drug for schizophrenia, a potential ‘game changer’

The U.S. Food and Drug Administration late Thursday approved a new kind of ... new approach to schizophrenia treatment ...

7m

Establishment Labs Jumps In Pre-market On FDA Approval Of Its Motiva Breast Implants

Shares of Establishment Labs Holdings Inc. (ESTA) were surging more than 21 percent in pre-market on Friday to $50.22, after its ...

1h

FDA approves new kind of drug for schizophrenia

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results